This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,025.56, is for the delivery of 4,567,240 units of the prescription medication Tamsulosin HCl 0.4 mg capsules. The contract is a Firm Fixed Price Delivery Order that runs through February 12, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 1,000 units of the medication Tamsulosin HCL 0.4 mg capsules, with a ceiling value of $16,741.76 and a completion date of March 4, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside requirements. AmerisourceBergen holds a significant Indefinite Delivery Contract...
The federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,437.67, is for the delivery of 4,567,253 units of Tamsulosin HCL 0.4 mg capsules. This is a Firm Fixed Price Delivery Order contract with a completion date of February 13, 2025. The contract is not designated with a set-aside. Amerisourcebergen holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $5,011.02 for the provision of 4,566,929,250 units of Tamsulosin HCL 0.4 mg capsules. The contract has an ultimate completion date of January 15, 2025 and is a Firm Fixed Price arrangement. This award is not designated under a set-aside program. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 1,000 units of the drug Tamsulosin HCL 0.4 mg capsules. The contract has a firm fixed price of $1,636.98 and an ultimate completion date of May 13, 2024. The contract is a Delivery Order and was awarded on May 10, 2024 with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,723.34, is for the delivery of 1000 units of the prescription medication Tamsulosin HCL 0.4 mg capsules. This is a firm fixed-price delivery order contract with a completion date of June 5, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,065.94, is for the supply of 4,567,222,444 units of Tamsulosin HCL 0.4 mg capsules. The contract has a firm fixed-price pricing type and a completion date of February 11, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,865.14, is for the delivery of 1,000 units of the medication Tamsulosin HCL 0.4 mg capsules. The contract has an ultimate completion date of November 21, 2023 and is a firm fixed-price delivery order. This award is associated with a larger Indefinite Delivery Contract (IDC) that...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,927.98, is for the delivery of 1,000 capsules of Tamsulosin HCL 0.4 mg, a medication used to treat benign prostatic hyperplasia. The contract is a Firm Fixed Price Delivery Order, with a completion date of January 15, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,699.60, is for the delivery of 1,000 units of the prescription medication Tamsulosin HCL 0.4 mg Capsule. The contract has an ultimate completion date of December 27, 2024 and was awarded on December 26, 2024. It is a firm fixed price delivery order contract with no set-aside designation,...